filmov
tv
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Показать описание
Yongqun He, Ph.D. - COVID-19 vaccine machine learning, ontology modeling, and Cov19VaxKB
U.S. Food and Drug Administration
Рекомендации по теме
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Innovative Trial Design Approaches: Model Informed Drug Development in Rare & Neurological Disea...
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Modeling informed drug development
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
How Can Model Informed Drug Development Impact Your Program?
MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness...
What is the importance of model-informed drug (MIDD) development?
Strategic Implementation of Model-informed Drug Development (MIDD) for Regulatory Success
Physiologically-based Pharmacokinetics Modeling: An Approach for Designing Better Clinical Trials